JASCAYD^® (Nerandomilast) Receives First Regulatory Approval for Progressive Pulmonary Fibrosis in China

China’s National Medical Products Administration has approved JASCAYD^® as the first new treatment for adults with progressive pulmonary fibrosis in more than five years, marking a breakthrough for millions affected by the life-threatening lung condition.